Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial

OBJECTIVE: Significant heterogeneity was observed in previous trials that assessed the efficacies of sequential therapy for 10 days (S10) versus triple therapy for 14 days (T14) in the first-line treatment of Helicobacter pylori. We aimed to compare the efficacy of S10 and T14 and assess the factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Liou, Jyh-Ming, Chen, Chieh-Chang, Chang, Chi-Yang, Chen, Mei-Jyh, Chen, Chien-Chuan, Fang, Yu-Jen, Lee, Ji-Yuh, Yang, Tsung-Hua, Luo, Jiing-Chyuan, Wu, Jeng-Yih, Liou, Tai-Cherng, Chang, Wen-Hsiung, Hsu, Yao-Chun, Tseng, Cheng-Hao, Chang, Chun-Chao, Bair, Ming-Jong, Liu, Tzeng-Ying, Hsieh, Chun-Fu, Tsao, Feng-Yun, Shun, Chia-Tung, Lin, Jaw-Town, Lee, Yi-Chia, Wu, Ming-Shiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Helicobacter Pylori
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099199/
https://www.ncbi.nlm.nih.gov/pubmed/26338825
http://dx.doi.org/10.1136/gutjnl-2015-310142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099199/
https://www.ncbi.nlm.nih.gov/pubmed/26338825
http://dx.doi.org/10.1136/gutjnl-2015-310142

Ejemplares similares